An important component of the Food and Drug Administration’s Sentinel Initiative is the active post-market risk identification and analysis (ARIA) system, which utilizes semi-automated, parameterized computer programs to implement propensity-score adjusted and self-controlled risk interval designs to conduct targeted surveillance of medical products in the Sentinel Distributed Database. In this manuscript, the authors review literature relevant to the development of these programs and describe their application within the Sentinel Initiative.
